Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HipromineWAR:HPM -2.52%56 EBIT per Share is zł-33.06 as of Mar. 2026. GuruFocus rates WAR:HPM with a GF Score™ of 56/100 and a GF Value™ of zł854.94 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 1,580 Consumer Packaged Goods companies, Hipromine ranks worse than 79.3% on this metric.
Hipromine's EBIT per Share for the
three
months ended in Mar. 2026 was zł-9.45.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was zł-33.06.
During the past 3 years, the average EBIT per Share Growth Rate was -12.60% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -32.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Hipromine's EBIT per Share or its related term are showing as below:
WAR:HPM'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -59.7 Med: -32.1 Max: -12.6
Current: -12.6
During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Hipromine was -12.60% per year. The lowest was -59.70% per year. And the median was -32.10% per year.
WAR:HPM's 3-Year EBIT Growth Rate is ranked worse than 79.3% of 1580
companies
in the Consumer Packaged Goods industry
Industry Median: 6.9
vs WAR:HPM: -12.60
Hipromine's EBIT for the
three
months ended in Mar. 2026 was zł-12.77 Mil.
Hipromine (WAR:HPM) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Hipromine EBIT per Share Related Terms
Hipromine EBIT per Share Historical Data
* Premium members only.
The historical data trend for Hipromine's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-33.06
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hipromine (WAR:HPM) has a EBIT per Share of zł-33.06 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Hipromine and its competitors. According to the industry distribution chart, Hipromine ranks #1253 out of 1580 companies in the Consumer Packaged Goods industry, placing it in the top 79.3%.
Is Hipromine's EBIT per Share too high?
Hipromine's current EBIT per Share is zł-33.06. Based on the distribution chart, Hipromine ranks #1253 out of 1580 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Hipromine has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hipromine's EBIT per Share compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Hipromine ranks #1253 out of 1580 companies for EBIT per Share. This places Hipromine in the lower half of its industry. The industry median EBIT per Share is 6.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Consumer Packaged Goods company?
The median EBIT per Share among Consumer Packaged Goods companies is 6.90, based on 1,580 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Hipromine and its competitors. For the Consumer Packaged Goods industry, the median EBIT per Share is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hipromine's current EBIT per Share is zł-33.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hipromine stock overvalued right now?
Based on GuruFocus' analysis, Hipromine (WAR:HPM) is currently considered Possible Value Trap. The stock's GF Value™ is zł854.94, compared to a current price of zł77.50 — trading 90.9% below its estimated fair value. The current EBIT per Share is zł-33.06. Hipromine's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Hipromine (WAR:HPM), the current EBIT per Share is zł-33.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hipromine (WAR:HPM) Overvalued in 2026?
Based on GuruFocus' analysis, Hipromine stock appears to be undervalued.
The current stock price of zł77.50 is trading 90.9% below its estimated GF Value™ of zł854.94.
GuruFocus considers Hipromine to be Possible Value Trap.
Key valuation signals for WAR:HPM:
EBIT per Share: zł-33.06
GF Value™: zł854.94 vs. price of zł77.50 (90.9% below fair value)
No single metric tells the full story. See the WAR:HPM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hipromine SA is a European scale supplier of an alternative protein produced through innovative, proprietary technology of industrial insect breeding. The company's offer is directed mainly to the market of pet food and fodder for fish farming, as well as livestock and horticulture.
56GF Score
Get the complete analysis for WAR:HPM
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:HPM has been successfully added to your 
